AMBARELLA INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data AMBARELLA INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	310	295	228	229	223	332	338	226	285	391
Cost of revenue	105	108	89.6	96	87.4	124	129	89.7	113	159
Gross profit	205	188	138	133	136	208	209	137	172	231
Research and development	101	116	128	130	141	167	205	215	226	239
Selling, general and administrative	43.4	47.8	50.5	52.6	56	70.4	78.2	76.3	72.8	75.3
Operating expenses	145	163	179	182	197	238	283	291	299	314
Operating income	60.4	24.4	-40.4	-49.6	-61.2	-29.6	-74.3	-155	-127	-82.5
Other non-operating income	0.52	1.3	5.87	8.02	3.86	1	3.32	6.03	8.87	8.83
Pre-tax income	60.9	25.7	-34.6	-41.6	-57.3	-28.6	-70.9	-149	-118	-73.7
Income tax	3.07	6.88	-4.11	3.16	2.48	-2.23	-5.55	20.9	-0.6	2.17
Net income	57.8	18.9	-30.4	-44.8	-59.8	-26.4	-65.4	-169	-117	-75.9
EBITDA	61.9	29.2	-33.2	-38	-49.2	-15.6	-54.3	-130	-101	-56.9
EPS, basic	1.77	0.57	-0.93	-1.35	-1.72	-0.72	-1.70	-4.25	-2.84	-1.78
EPS, diluted	1.68	0.55	-0.93	-1.35	-1.72	-0.72	-1.70	-4.25	-2.84	-1.78
Shares, basic (weighted)	32.7	33.2	32.7	33.1	34.7	36.6	38.4	39.9	41.3	42.7
Shares, diluted (weighted)	34.3	34.6	32.7	33.1	34.7	36.6	38.4	39.9	41.3	42.7

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	323	347	194	231	241	171	114	145	145	191
Short-term investments		87.9	165	173	199	0	93.3	75	106	122
Receivables	38.6	31.3	26.2	18.5	25	44.3	52	25	29.8	39.2
Inventory	20.1	23.4	18.3	23	26.1	45.2	40.5	29	34.4	52.2
Other current assets	4.39	4.01	6.21	4.98	5.53	6.17	5.29	6.23	6.08	5.84
Total current assets	469	493	410	451	497	267	305	280	321	410
Property, plant and equipment	4.99	6.45	5.61	5.61	5.53	10.1	11.8	10.4	9.08	11.6
Lease right-of-use assets			0	9.94	9.66	11.1	8.34	5.25	5.19	12.1
Goodwill	26.6	26.6	26.6	26.6	26.6	304	304	304	304	304
Intangible assets	4.15	14.4	10.9	17.8	18.7	46.3	58.5	55.1	47.3	58
Other non-current assets	2.22	2.26	2.41	5.71	4.57	4.27	4.01	3.05	3.24	2.98
Total assets	512	547	467	527	573	658	710	658	689	799
Accounts payable	20	19.8	12.8	14.9	21.1	31.2	17.8	28.5	21.8	54
Accrued liabilities	26.4	16	10.6	16.9	18.1	30	56.7	48.6	80.8	98
Deferred revenue	7.43	0.31	0.53	0.7	0.84	1.41	1.31	0.89	14.2	22.4
Total current liabilities	54.4	53.2	39	53.5	74	89.3	83.5	83	121	178
Lease liabilities			0	7.98	7.53	8.32	5.1	1.9	2.44	11.4
Other non-current liabilities	3.24	11.2	8.34	17.8	16.8	12.8	15.5	12.9	4.13	14.5
Total liabilities	57.6	64.5	47.4	79.2	98.3	110	104	97.8	128	204
Paid-in capital	212	221	189	261	347	447	572	695	814	922
Retained earnings	242	261	231	186	126	99.9	34.5	-135	-252	-328
Other comprehensive income	-0.07	-0.28	0.1	0.77	1.22	0	-0.49	-0.18	-0.23	0.57
Shareholders' equity	455	482	419	448	475	547	606	560	561	595
Total equity	455	482	419	448	475	547	606	560	561	595
Total liabilities and equity	512	547	467	527	573	658	710	658	689	799
Shares outstanding	33.4	33.5	32.3	33.8	35.5	37.3	39	40.5	42	43.3

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	57.8	18.9	-30.4	-44.8	-59.8	-26.4	-65.4	-169	-117	-75.9
Depreciation and amortization	1.59	4.77	7.22	11.6	12	14	19.9	24.8	26.1	25.6
Stock-based compensation	48.8	56.9	60.8	66.9	70.1	87.8	111	111	108	98
Deferred income tax	1.01	2.12	-6.96	0.18	-0.5	-4.92	-4.6	18.9	-0.35	-0.18
Change in receivables	0.81	7.3	5.08	7.73	-6.49	-18.6	-7.68	27	-4.82	-9.41
Change in inventory	-1.98	-3.24	5.13	-4.72	-3.11	-18.9	4.73	11.4	-5.21	-17.9
Change in payables	5.78	-0.14	-7.01	2.11	6.21	9.82	-13.3	10.7	-9.58	33.7
Cash from operations	113	85.4	24.5	39.4	30.8	38.8	44.1	19	33.8	73.5
Capital expenditures	-2.7	-3.69	-2.94	-1.82	-1.95	-9.68	-15.1	-12	-10.4	-15.5
Acquisitions	0	0		0	0	-307	0	0
Purchases of investments	-116	-74.9	-208	-226	-220	-119	-97.4	-34.2	-70.7	-62.6
Sales and maturities of investments	41.4	58.1	65.4	123	123	108	2	46.9	19.1	28.9
Cash from investing	-45.7	-9.6	-79.1	-8.58	-31.3	-120	-107	7.84	-40.5	-30.5
Share buybacks	-20.2	-54.8	-99.9	0	-1	0	0	0	0	-1
Cash from financing	-12.8	-52	-98	6.52	10.4	10.5	5.7	4.51	6.4	3.81
Net change in cash	54.8	23.8	-153	37.4	9.87	-70.2	-57.5	31.4	-0.29	46.8
Free cash flow	111	81.7	21.5	37.6	28.8	29.1	29	7.05	23.5	58
Income taxes paid	2.07	0.85	1.41	1.81	1.53	1.87	1.44	7.11	1.42	2.27

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 31, 2026; growth uses fiscal years. Valuation uses the share price of $72.68 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	58.5%	Gross profit / revenue.
Operating margin	-14.9%	Operating income / revenue.
EBITDA margin	-12.5%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-12.9%	Pre-tax income / revenue.
Net margin	-13.5%	Net income / revenue.
FCF margin	2.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	6.5%	Cash from operations / revenue.
Return on equity (ROE)	-9.1%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-7.2%	Net income / average total assets.
Return on invested capital (ROIC)	-9.5%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	54.7%	Research and development expense / revenue.
SG&A / revenue	18.7%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	21.9%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	4.2%	Capital expenditures / revenue.
D&A / revenue	2.4%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	37.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	5.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	11.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	34.2%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	3.4%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	11.3%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	117.3%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	18.6%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	19.0%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	147.3%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	25.9%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	15.0%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	5.9%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-0.6%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	4.6%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	15.9%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	4.0%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	6.9%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	3.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	3.6%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	4.3%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.85x	Current assets / current liabilities.
Quick ratio	2.24x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	1.97x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	20.5%	Total liabilities / total assets.
Working capital	$255.7M	Current assets - current liabilities.
Goodwill and intangibles / assets	46.2%	(Goodwill + intangible assets) / total assets.
Tangible book value	$260.0M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.54x	Revenue / average total assets.
Fixed asset turnover	34.6x	Revenue / average property, plant and equipment.
Inventory turnover	2.25x	Cost of revenue / average inventory.
Days inventory	162 days	365 x average inventory / cost of revenue.
Receivables turnover	11.2x	Revenue / average receivables.
Days sales outstanding	33 days	365 x average receivables / revenue.
Days payables	56 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	139 days	Days inventory + days sales outstanding - days payables.
Capex / operating cash flow	64.4%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$1.28	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$9.49	Revenue / diluted weighted shares.
FCF per share	$0.22	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.62	Cash from operations / diluted weighted shares.
Book value per share	$14.05	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$5.89	Tangible book value / shares outstanding.
Cash per share	$6.17	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	25.1%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$3.19B	Share price x shares outstanding.
Enterprise value	$2.92B	Market cap + total debt - cash - short-term investments.
P/S	7.63x	Market cap / revenue.
P/B	5.14x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	12.3x	Market cap / tangible book value, when positive.
P/FCF	328x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	117x	Market cap / cash from operations, when positive.
EV/Sales	6.98x	Enterprise value / revenue.
EV/FCF	300x	Enterprise value / free cash flow, when both are positive.
FCF yield	0.3%	Free cash flow / market cap.
Earnings yield	-1.8%	Net income / market cap (the inverse of P/E).
Shareholder yield	0.1%	(Dividends paid + share buybacks) / market cap.

What was AMBARELLA INC's revenue in fiscal 2026?

AMBARELLA INC reported revenue of $390.7M for fiscal 2026, 37.2% higher than the year before.

Was AMBARELLA INC profitable in fiscal 2026?

No. It reported a net loss of $75.9M.

How much free cash flow did AMBARELLA INC generate in fiscal 2026?

Cash from operations of $73.5M minus capital expenditures of $15.5M left free cash flow of $58.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to AMBARELLA INC